Skip to content
MedsAcross

Medicine

Ropivacaine 400 mg/200 mL injection

Ropivacaine · Epidural, infiltration
Available on requestPrescription onlyUS FDAGeneric name

Ropivacaine 400 mg/200 mL injection is a generic prescription medicine for epidural, infiltration use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Ropivacaine
Brand
Sold under the generic name
Strength
400 mg/200 mL
Dosage form
Injection
Route
Epidural, infiltration
Packs
10 pouches of 200 mL, 1 bag of 200 mL, 10 bags of 200 mL and 2 more
Manufacturers
Caplin SterilesIndiaGland PharmaIndiaSagent PharmaceuticalsBaxter Healthcare
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 December 2018
Identifiers
RxCUI 1734347, 1734355, 1734479 +5DailyMed set ID 8c5c762f-d266-4b1a-809e-f11bfc89bc2d, 9572b3de-684c-4028-a577-5aa69ba6b02d, e057aeb2-5125-490c-b691-847426fd42d0 +2NDC 25021-671, 43066-154, 65145-166 +1Application ANDA206166, ANDA210102, ANDA212808

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 pouch in 1 case / 1 bag in 1 pouch / 200 mL in 1 bag65145-166-10Caplin SterilesIndia24 June 2025
1 bag in 1 pouch / 200 mL in 1 bag68083-263-01Gland PharmaIndia18 August 2022
10 bag in 1 carton / 200 mL in 1 bag25021-671-67Sagent Pharmaceuticals1 January 2020
10 bag in 1 carton / 200 mL in 1 bag25021-671-87Sagent Pharmaceuticals15 December 2018
10 bag in 1 carton / 200 mL in 1 bag43066-154-10Baxter Healthcare1 January 2024
12 pouch in 1 carton / 1 bag in 1 pouch / 200 mL in 1 bag70121-1733-3—4 December 2023
24 pouch in 1 carton / 1 bag in 1 pouch / 200 mL in 1 bag70121-1733-9—17 March 2023
24 bag in 1 case / 200 mL in 1 bag65219-632-20—3 February 2025
12 bag in 1 case / 200 mL in 1 bag0143-9196-12—7 November 2025
10 pouch in 1 carton / 1 bag in 1 pouch / 200 mL in 1 bag67457-799-99—18 March 2024
24 bag in 1 carton / 200 mL in 1 bag70512-798-24—1 March 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 September 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ropivacaine 400 mg/200 mL injection.

Compare all 2

Other strengths and forms of Ropivacaine

Clinical summary

Ropivacaine is an amide local anesthetic indicated for the production of local or regional anesthesia for surgery and for acute pain management. It is available as injection for epidural, infiltration and perineural use. MedsAcross supplies Ropivacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ropivacaine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ropivacaine 400 mg/200 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.